全文获取类型
收费全文 | 10245篇 |
免费 | 902篇 |
国内免费 | 341篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 103篇 |
妇产科学 | 71篇 |
基础医学 | 1757篇 |
口腔科学 | 490篇 |
临床医学 | 821篇 |
内科学 | 1478篇 |
皮肤病学 | 829篇 |
神经病学 | 1829篇 |
特种医学 | 232篇 |
外国民族医学 | 5篇 |
外科学 | 656篇 |
综合类 | 1132篇 |
现状与发展 | 3篇 |
预防医学 | 407篇 |
眼科学 | 142篇 |
药学 | 508篇 |
11篇 | |
中国医学 | 184篇 |
肿瘤学 | 774篇 |
出版年
2024年 | 28篇 |
2023年 | 136篇 |
2022年 | 245篇 |
2021年 | 371篇 |
2020年 | 347篇 |
2019年 | 358篇 |
2018年 | 325篇 |
2017年 | 333篇 |
2016年 | 317篇 |
2015年 | 377篇 |
2014年 | 601篇 |
2013年 | 678篇 |
2012年 | 509篇 |
2011年 | 606篇 |
2010年 | 552篇 |
2009年 | 536篇 |
2008年 | 550篇 |
2007年 | 522篇 |
2006年 | 565篇 |
2005年 | 447篇 |
2004年 | 405篇 |
2003年 | 369篇 |
2002年 | 295篇 |
2001年 | 244篇 |
2000年 | 189篇 |
1999年 | 127篇 |
1998年 | 166篇 |
1997年 | 146篇 |
1996年 | 135篇 |
1995年 | 102篇 |
1994年 | 86篇 |
1993年 | 76篇 |
1992年 | 82篇 |
1991年 | 62篇 |
1990年 | 58篇 |
1989年 | 49篇 |
1988年 | 44篇 |
1987年 | 52篇 |
1986年 | 58篇 |
1985年 | 77篇 |
1984年 | 54篇 |
1983年 | 48篇 |
1982年 | 46篇 |
1981年 | 44篇 |
1980年 | 34篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1977年 | 4篇 |
1976年 | 6篇 |
1974年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Diagnostic Histopathology》2022,28(3):156-160
Breast core biopsies are a standard component of the triple approach that includes clinical examination, imaging and tissue sampling. Conventional cores, diagnostic vacuum assisted biopsy and vacuum assisted excisions are established methods for sampling and managing breast lesions. It is important to be aware of the potential pitfalls in the technical handling and interpretation of the limited core biopsy samples. Here, we present a clinically oriented, well illustrated overview of the common diagnostic pitfalls based on the author's diagnostic and second opinion practice, emphasize the value of clinicopathological correlation and provide histological tips and clues with useful immunohistochemistry to aid the reporting pathologists in their daily interpretation of breast core biopsies. 相似文献
2.
3.
María del Carmen Azorín Samper Marta Hernandorena Gonzlez Alberto Ibez Arias Sandra Díaz Sierra Marta Bertolo Domínguez Flix Checa Ayet 《The breast journal》2020,26(2):252-254
Breast pseudoaneurysms after a core needle biopsy are a rare complication with a low incidence. However, it is important to be aware of the possibility of complications that require treatment. 相似文献
4.
《Anais brasileiros de dermatologia》2019,94(1):42-46
BackgroundSkin cancer is a highly prevalent condition with a multifactorial etiology resulting from genetic alterations, environmental and lifestyle factors. In Brazil, among all malignant tumors, skin cancers have the highest incidences.ObjectiveTo retrospectively evaluate the incidence, prevalence and profile of basal cell carcinoma, squamous cell carcinoma and cutaneous melanoma in Campos dos Goytacazes and region.Methods:In total, 2,207 histopathological reports of a local reference hospital were analyzed between January 2013 and December 2015, of which 306 corresponded to the neoplasms studied.Results:Of the 306 reports evaluated, 232 basal cell carcinomas (75.9%), 55 squamous cell carcinomas (18%) and 19 cutaneous melanomas (6.5%) were identified. The face was the most involved anatomical site (58.8%) and women (51%) were the most affected gender. The temporal analysis revealed a decrease in the overall incidence of 3.4% from 2013 to 2014 and 5.4% from 2014 to 2015. There was a 10.1% increase in basal cell carcinomas and 38% in melanomas in this period; however, there was a decrease in the number of squamous cell carcinomas of 14.8% during the studied years.Study limitations:Some samples of cutaneous fragments had no identification of the anatomical site of origin.Conclusion:Research that generates statistical data on cutaneous tumors produces epidemiological tools useful in the identification of risk groups and allows the adoption of more targeted and efficient future prevention measures. 相似文献
5.
6.
7.
A developmental validation was performed to demonstrate reliability, reproducibility and robustness of the ANDE System with the FlexPlex assay, including an integrated Expert System, across a number of laboratories and buccal sample variations. Previously, the related DNAscan™/ANDE 4C Rapid DNA System using the PowerPlex®16 assay and integrated Expert System Software received NDIS approval in March 2016. The enhanced ANDE instrument, referred to as ANDE 6C, and the accompanying 6-dye, 27-locus STR assay, referred to as FlexPlex, have been developed to be compatible with all widely used global loci, including the expanded set of the CODIS core 20 loci.Six forensic and research laboratories participated in the FlexPlex Rapid DNA developmental validation experiments, testing a total of 2045 swabs, including those obtained from 1387 unique individuals. The goal of this extensive and comprehensive validation was to thoroughly evaluate and document the ANDE System and its internal Expert System to reliably genotype reference buccal swab samples in a manner compliant with the FBI’s Quality Assurance Standards and the NDIS Operational Procedures.The ANDE System, including automated Expert System analysis, generated reproducible and concordant results for buccal swabs when testing various instruments at different laboratories by a number of different operators. When testing a number of non-human DNAs, including oral bacteria, the ANDE System and FlexPlex assay demonstrated limited cross-reactivity. Potential PCR inhibitors were evaluated as part of the validation and no inhibition was detected. Reproducible and concordant profiles were generated from buccal swab samples collected with a limit of detection appropriate for buccal swab collections from arrestees. The precision and resolution of the System met industry standards for detection of microvariants and single base resolution.The integrated Expert System appropriately demonstrated the ability to correctly pass or fail profiles for CODIS upload without human review. During this comprehensive developmental validation, the ANDE System successfully interpreted over 2000 samples tested with over 99.99% concordant alleles. The data package described herein led to the ANDE System with the FlexPlex assay receiving NDIS approval in June 2018. 相似文献
8.
9.
10.